基于放射组学特征和深度学习的临床融合模型,用于预测 IDH 突变弥漫性星形细胞瘤的 CDKN2A/B 基因同源缺失状态

Linling Wang, Yao Tang, Hongyu Pan, Zhi-Fei Wen, Xu Cao, Zhi Liu, Ming Wen, Liqiang Zhang
{"title":"基于放射组学特征和深度学习的临床融合模型,用于预测 IDH 突变弥漫性星形细胞瘤的 CDKN2A/B 基因同源缺失状态","authors":"Linling Wang, Yao Tang, Hongyu Pan, Zhi-Fei Wen, Xu Cao, Zhi Liu, Ming Wen, Liqiang Zhang","doi":"10.56397/crms.2024.06.07","DOIUrl":null,"url":null,"abstract":"Purpose: To construct a fusion model for predicting CDKN2A/B homozygous deletion status in patients with isocitrate dehydrogenase (IDH)-mutant diffuse astrocytoma by combining the radiomics features and deep learning (DL). Methods: A total of 200 IDH-mutant astrocytoma (103 CDKN2A/B homozygous deletion (HD) and 97 CDKN2A/B non-homozygous deletion (NHD)) patients were retrospectively enrolled in the training cohort (n = 140) and the external test cohort (n = 60) for the prediction of CDKN2A/B homozygous deletion status in patients with IDH-mutant astrocytoma. DL model was constructed by SE-Net model, radiomics features of different regions (edema, tumor and overall lesion) were extracted using Pyradiomics, and radiomics model was built by selecting 4 features in the edema region and 7 features in the tumor region by the least absolute shrinkage and selection operator (LASSO). Finally, a fusion model was jointly constructed by the DL model, radiomics model, and clinical features. The predictive performance of the 3 models was evaluated using calibration curves and decision curves, and compared with the fusion model. Results: Based on the results of the different models, we finally selected a fusion model consisting of DL model, radiomics model, and clinical features. The fusion model showed the best performance with an area under the curve (AUC) of 0.958 in the training cohort and 0.914 in the test cohort. Conclusions: The clinical fusion model based on radiomics features and DL features showed good performance in predicting CDKN2A/B homozygous deletion status in patients with IDH-mutant diffuse astrocytoma. Key Points: 1) Used DL and radiomics to non-invasively predict the CDKN2A/B homozygous deletion status. 2) The model can predict CDKN2A/B homozygous deletion status in IDH-mutant astrocytoma patients. 3) Our result improved classification accuracy and demonstrated better performance in the fusion model.","PeriodicalId":72751,"journal":{"name":"Current research in medical sciences","volume":"13 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Clinical Fusion Model Based on Radiomics Features and Deep Learning for Predicting CDKN2A/B Homozygous Deletion Status in IDH-mutant Diffuse Astrocytoma\",\"authors\":\"Linling Wang, Yao Tang, Hongyu Pan, Zhi-Fei Wen, Xu Cao, Zhi Liu, Ming Wen, Liqiang Zhang\",\"doi\":\"10.56397/crms.2024.06.07\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose: To construct a fusion model for predicting CDKN2A/B homozygous deletion status in patients with isocitrate dehydrogenase (IDH)-mutant diffuse astrocytoma by combining the radiomics features and deep learning (DL). Methods: A total of 200 IDH-mutant astrocytoma (103 CDKN2A/B homozygous deletion (HD) and 97 CDKN2A/B non-homozygous deletion (NHD)) patients were retrospectively enrolled in the training cohort (n = 140) and the external test cohort (n = 60) for the prediction of CDKN2A/B homozygous deletion status in patients with IDH-mutant astrocytoma. DL model was constructed by SE-Net model, radiomics features of different regions (edema, tumor and overall lesion) were extracted using Pyradiomics, and radiomics model was built by selecting 4 features in the edema region and 7 features in the tumor region by the least absolute shrinkage and selection operator (LASSO). Finally, a fusion model was jointly constructed by the DL model, radiomics model, and clinical features. The predictive performance of the 3 models was evaluated using calibration curves and decision curves, and compared with the fusion model. Results: Based on the results of the different models, we finally selected a fusion model consisting of DL model, radiomics model, and clinical features. The fusion model showed the best performance with an area under the curve (AUC) of 0.958 in the training cohort and 0.914 in the test cohort. Conclusions: The clinical fusion model based on radiomics features and DL features showed good performance in predicting CDKN2A/B homozygous deletion status in patients with IDH-mutant diffuse astrocytoma. Key Points: 1) Used DL and radiomics to non-invasively predict the CDKN2A/B homozygous deletion status. 2) The model can predict CDKN2A/B homozygous deletion status in IDH-mutant astrocytoma patients. 3) Our result improved classification accuracy and demonstrated better performance in the fusion model.\",\"PeriodicalId\":72751,\"journal\":{\"name\":\"Current research in medical sciences\",\"volume\":\"13 11\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current research in medical sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.56397/crms.2024.06.07\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current research in medical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56397/crms.2024.06.07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:通过结合放射组学特征和深度学习(DL),构建一个用于预测异柠檬酸脱氢酶(IDH)突变弥漫性星形细胞瘤患者 CDKN2A/B 基因同源缺失状态的融合模型。研究方法为预测IDH突变星形细胞瘤患者的CDKN2A/B同基因缺失状态,回顾性地将200名IDH突变星形细胞瘤患者(103名CDKN2A/B同基因缺失(HD)和97名CDKN2A/B非同基因缺失(NHD))纳入训练队列(n = 140)和外部测试队列(n = 60)。通过SE-Net模型构建DL模型,使用Pyradiomics提取不同区域(水肿、肿瘤和整体病变)的放射组学特征,并通过最小绝对收缩和选择算子(LASSO)选择水肿区域的4个特征和肿瘤区域的7个特征,构建放射组学模型。最后,由 DL 模型、放射组学模型和临床特征共同构建了一个融合模型。利用校准曲线和决策曲线评估了这三种模型的预测性能,并与融合模型进行了比较。结果:根据不同模型的结果,我们最终选择了由 DL 模型、放射组学模型和临床特征组成的融合模型。融合模型表现最佳,在训练队列中的曲线下面积(AUC)为 0.958,在测试队列中为 0.914。结论基于放射组学特征和DL特征的临床融合模型在预测IDH突变弥漫性星形细胞瘤患者的CDKN2A/B同源缺失状态方面表现良好。要点1)利用DL和放射组学无创预测CDKN2A/B同源缺失状态。2)该模型可预测 IDH 突变星形细胞瘤患者的 CDKN2A/B 基因缺失状态。3) 我们的结果提高了分类准确性,并在融合模型中表现出更好的性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Clinical Fusion Model Based on Radiomics Features and Deep Learning for Predicting CDKN2A/B Homozygous Deletion Status in IDH-mutant Diffuse Astrocytoma
Purpose: To construct a fusion model for predicting CDKN2A/B homozygous deletion status in patients with isocitrate dehydrogenase (IDH)-mutant diffuse astrocytoma by combining the radiomics features and deep learning (DL). Methods: A total of 200 IDH-mutant astrocytoma (103 CDKN2A/B homozygous deletion (HD) and 97 CDKN2A/B non-homozygous deletion (NHD)) patients were retrospectively enrolled in the training cohort (n = 140) and the external test cohort (n = 60) for the prediction of CDKN2A/B homozygous deletion status in patients with IDH-mutant astrocytoma. DL model was constructed by SE-Net model, radiomics features of different regions (edema, tumor and overall lesion) were extracted using Pyradiomics, and radiomics model was built by selecting 4 features in the edema region and 7 features in the tumor region by the least absolute shrinkage and selection operator (LASSO). Finally, a fusion model was jointly constructed by the DL model, radiomics model, and clinical features. The predictive performance of the 3 models was evaluated using calibration curves and decision curves, and compared with the fusion model. Results: Based on the results of the different models, we finally selected a fusion model consisting of DL model, radiomics model, and clinical features. The fusion model showed the best performance with an area under the curve (AUC) of 0.958 in the training cohort and 0.914 in the test cohort. Conclusions: The clinical fusion model based on radiomics features and DL features showed good performance in predicting CDKN2A/B homozygous deletion status in patients with IDH-mutant diffuse astrocytoma. Key Points: 1) Used DL and radiomics to non-invasively predict the CDKN2A/B homozygous deletion status. 2) The model can predict CDKN2A/B homozygous deletion status in IDH-mutant astrocytoma patients. 3) Our result improved classification accuracy and demonstrated better performance in the fusion model.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信